Fasenra Injection Therapy

What is Fasenra?

Fasenra (benralizumab) is a biologic drug therapy that is an add-on maintenance treatment for patients 12 years and older with ​severe eosinophilic asthma (EA). 

How does Fasenra work?

Eosinophils are normal white blood cells. People with eosinophilic asthma have increased levels of eosinophils, which worsens inflammation in their lungs and can cause severe asthma attacks. Fasenra has been proven to reduce eosinophil levels in the blood, which helps prevent asthma attacks, improves breathing and lung function, and better controls asthma symptoms. Taking Fasenra may reduce or completely eliminate a patient’s need to take oral steroids daily. 

How is Fasenra administered?

Fasenra is administered via injection. The first 3 doses are administered once every 4 weeks, and then once every 8 weeks thereafter. 

Click here to visit the pharmaceutical website for Fasenra.

Fasenra PATIENT Assistance PROGRAM

• FASENRA Savings Program

This product may be used to treat other conditions not listed. If you are currently using or have a physician’s order to begin using this product for an unlisted condition and you have questions about whether or not we can offer you infusion services, please call our office or fill out a form and a member of our team will reach out to you as soon as possible.

If you’d like more information about the other treatment options we offer, please visit the IVIg infusions or IV infusions pages to learn more.